An investigation reveals the proliferation of unregulated stem cell clinics across the United States marketing experimental longevity treatments without scientific evidence. These facilities exploit consumer desire for anti-aging solutions, promoting therapies that lack peer-reviewed validation. Medical experts warn that such unproven interventions pose serious health risks, while regulatory gaps allow providers to operate with minimal oversight. The booming market capitalizes on aging anxieties, raising concerns about patient safety and the need for stricter regulatory enforcement.

Summary auto-generated by AI from the original publisher's content. Editorial standards.